SEC Form D · filed January 6, 2023
Outlook Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (30)
Faisal G. Sukhtian · Iselin, NJDirectorLawrence A. Kenyon · Iselin, NJExec · DirectorRandy H. Thurman · Iselin, NJDirectorAndong G. Huang · Iselin, NJDirectorYezan H. Haddadin · Iselin, NJDirectorJulia A. Haller · Iselin, NJDirectorJulian G. Gangolli · Iselin, NJDirectorKurt J. Hilzinger · Iselin, NJDirectorC. R. Trenary · Iselin, NJExec · DirectorGerd G. Auffarth · Iselin, NJDirectorJames Bracken · Schaumburg, ILDirectorM. W. Macey, Jr · Greenwich, CTDirectorJoseph J. Gault · Greenwich, CTDirectorMelvyn Reznick · Reno, NVExec · DirectorMark H. Barineau · Houston, TXDirectorMichael A. Barr · Greenwich, CTDirectorRajesh Sharma · Saint-Laurent, Quebec, CanadaDirectorAlan Pierrot · Fresno, CADirectorLuke Terrell · Fayetteville, ARDirectorGilles Lamarre · Ottawa, Ontario, CanadaExec · DirectorAvraham D. Dreyfuss · New York, NYDirectorMichael A. Scott · San Francisco, CADirectorAubrey Rankin · AUSTIN, TXDirectorDon Maniccia · AUSTIN, TXDirectorJared Hoffman · New York, NYDirectorNikolaos Perros · New York, NYDirectorLu Cai · New York, NYExec · DirectorXiao Jian Wang · New York, NYDirectorYun Zhang · New York, NYExec · DirectorLei Zhang · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗